VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
NGVT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
NGVTIngevity Corporation
$72.41$2.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksNGVTBalance Sheet

Ingevity Corporation (NGVT) Balance Sheet

13Y historyFree accessUpdated daily

Equity has collapsed 92% from $568.2M in Q1 2024 to $46.9M in Q2 2026, driving debt-to-equity to 26.36, though total debt remained near $1.2B and cash rose to $97.4M.

Income StatementBalance SheetCash FlowRatios

NGVT Balance Sheet

Annual statement

NGVT Balance Sheet

Ingevity Corporation (NGVT) balance sheet — 13-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Total Current Assets543.8M391.3M493.2M658.6M683.3M724.9M628.7M463.2M422.7M369.3M295.2M299M271M228M
Cash & Short-Term Investments97.4M78.1M68M95.9M76.7M275.4M257.7M56.5M77.5M87.9M30.5M32M20M12M
Cash Only97.4M78.1M68M95.9M76.7M275.4M257.7M56.5M77.5M87.9M30.5M32M20M12M
Short-Term Investments00000000000000
Accounts Receivable155.8M127.2M172M211M249.3M191.4M166.7M156.2M124M102.4M95.4M95.2M115M107M
Days Sales Outstanding50.3639.7644.6445.5154.5450.2150.0344.139.9338.4438.3435.940.3239.85
Inventory154M186M226.8M308.8M335M241.2M189M212.5M191.4M160M151.2M151M130M103M
Days Inventory Outstanding98.4896.1586.9892.37111.34100.1991.9195.6597.4690.7787.0680.2366.0954.88
Other Current Assets136.6M018.2M33.4M12.5M7.1M6.8M34.6M26.6M16.9M21.4M17.5M11M6M
Total Non-Current Assets993.7M871.6M1.53B1.96B2.05B1.74B1.71B1.68B892.5M561M537.6M483M447M365M
Property, Plant & Equipment608M608.1M709.3M829.3M855.2M772.1M752.7M664.7M523.8M438.5M422.7M438M410M326M
Fixed Asset Turnover1.83x1.92x1.98x2.04x1.95x1.80x1.62x1.95x2.16x2.22x2.15x2.21x2.54x3.01x
Goodwill4.3M4.3M175.2M527.5M518.5M442M445.3M439M130.7M12.4M12.4M12M13M13M
Intangible Assets137.3M176.1M323.9M385.3M455.8M378.7M397.3M396.2M125.6M23.4M18.1M21M13M16M
Long-Term Investments354.6M83.1M87.3M99.2M109.8M35.3M072.6M71.2M71.3M69.7M000
Other Non-Current Assets73.7M-117M115.2M111.8M108.2M109.2M102.4M103.7M38.3M12M11.3M12M11M10M
Total Assets1.54B1.65B2.02B2.62B2.74B2.47B2.33B2.14B1.32B930.3M832.8M782M718M593M
Asset Turnover0.70x0.71x0.70x0.65x0.61x0.56x0.52x0.60x0.86x1.05x1.09x1.24x1.45x1.65x
Asset Growth %-73.31%-18.37%-22.9%-4.14%10.83%5.76%8.87%63.05%41.37%11.71%6.5%8.91%21.08%-
Total Current Liabilities337.6M341.3M264.1M362.9M303.5M268.9M223.4M215.5M183.3M154M136.9M97M139M106M
Accounts Payable88M92M94.5M158.4M174.8M125.8M104.2M99.1M92.9M83.1M79.2M64.8M105M72M
Days Payables Outstanding48.8747.5636.2447.3858.152.2650.6744.6147.3147.1445.634.4353.3838.37
Short-Term Debt144M47.1M61.3M84.4M900K19.6M26M39.6M11.2M9.4M7.5M9.4M3M0
Deferred Revenue (Current)0000000-6.3M25.5M10.6M11.8M0-3M0
Other Current Liabilities014.7M500K15.1M6.9M1.1M1.1M16.2M37.2M21.5M24.6M14.8M1M1M
Current Ratio1.61x1.15x1.87x1.81x2.25x2.70x2.81x2.15x2.31x2.40x2.16x3.08x1.95x2.15x
Quick Ratio1.15x0.60x1.01x0.96x1.15x1.80x1.97x1.16x1.26x1.36x1.05x1.53x1.01x1.18x
Cash Conversion Cycle99.9688.3595.3890.5107.7998.1491.2795.1490.0882.0679.7981.6953.0356.37
Total Non-Current Liabilities1.15B1.28B1.56B1.63B1.73B1.53B1.47B1.4B792.3M498.6M561.3M163M159M159M
Long-Term Debt1.06B1.06B1.24B1.38B1.47B1.25B1.27B1.15B741.2M444M481.3M80M86M86M
Capital Lease Obligations191.9M120M135.7M48.6M40.8M36.2M34.7M36.7M73.9M80M80M80M86M0
Deferred Tax Liabilities211M57.3M56.2M70.9M106.5M114.6M117M103M37.2M41.3M69.8M76M67M63M
Other Non-Current Liabilities28.7M39M130.6M126.7M114.9M125.5M49.9M109.9M-59.1M-66.8M-69.8M1.5M-80M10M
Total Liabilities1.49B1.62B1.83B1.99B2.04B1.8B1.69B1.61B975.6M652.6M698.2M260M298M265M
Total Debt1.24B1.24B1.45B1.53B1.53B1.32B1.34B1.23B741.2M444M481.3M89M89M86M
Net Debt1.14B1.16B1.39B1.44B1.45B1.05B1.09B1.17B663.7M356.1M450.8M57M69M74M
Debt / Equity26.36x41.84x7.45x2.43x2.19x1.96x2.09x2.31x2.18x1.52x3.38x0.17x0.21x0.26x
Debt / EBITDA3.54x3.37x3.95x4.05x3.40x3.17x3.52x2.98x2.32x1.83x2.42x0.44x0.36x0.38x
Net Debt / EBITDA3.27x3.16x3.77x3.79x3.23x2.51x2.84x2.84x2.07x1.46x2.26x0.28x0.28x0.33x
Interest Coverage1.39x-0.89x-4.48x0.89x5.36x4.15x5.99x5.08x7.92x11.20x8.31x8.22x13.35x14.77x
Total Equity46.9M29.7M195.2M631.4M698.3M673.8M642.1M530.8M339.6M291.7M142.2M522M420M328M
Equity Growth %-264.96%-84.78%-69.08%-9.58%3.64%4.94%20.97%56.3%16.42%105.13%-72.76%24.29%28.05%-
Book Value per Share1.320.825.3717.3018.1516.8215.4512.587.976.863.3612.419.987.80
Total Shareholders' Equity46.9M29.7M195.2M631.4M698.3M673.8M642.1M530.8M339.6M277.7M134.6M517M417M326M
Common Stock400K400K400K400K400K400K400K400K400K400K400K530.1M424M326M
Retained Earnings500M404.9M572M1B1.01B796.1M678M497.2M313.5M142.8M16M000
Treasury Stock-663.6M-571.8M-512.6M-509.5M-416M-272.1M-162.3M-74.6M-55.8M-7.7M-300K000
Accumulated OCI1M500K-41.4M-26.7M-46.8M13.1M4.7M-5M-17.7M-11.7M-19M-17M-7M-421M
Minority Interest00000000014M7.6M5M3M2M

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

EV transition and CTO costs

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Equity Erosion Signals Structural Stress

Total equity collapsed from $568.2M in Q1 2024 to just $46.9M by Q2 2026, a 92% decline, according to the latest balance sheet data, indicating persistent losses and asset write-downs.

The balance sheet has weakened dramatically over the past ten quarters, with equity nearly wiped out. This erosion is driven by cumulative net losses and significant goodwill impairments, as evidenced by the drop in goodwill from $525.9M to $4.3M. The trend suggests that prior acquisitions have not generated expected returns, and the company's capital base is now extremely thin, raising questions about its financial resilience.

Leverage Spikes as Equity Vanishes

Debt-to-equity surged from 2.74 in Q1 2024 to 26.36 in Q2 2026, while total debt remained near $1.2B, as reported in the balance sheet, reflecting a dangerously high leverage profile.

The D/E ratio has skyrocketed not because debt increased significantly, but because equity has been decimated. With equity at only $46.9M, the company is highly leveraged, and any further losses could push equity negative. This leverage appears to be a consequence of necessity rather than strategic choice, as the company has had to maintain debt levels despite shrinking earnings power. The elevated leverage increases refinancing risk, especially if interest rates remain high or cash flows deteriorate further.

Asset Base Shrinks with Impairments

Total assets fell from $2.6B to $1.5B over the period, with goodwill plummeting from $525.9M to $4.3M, based on reported figures, indicating massive write-downs and a leaner asset base.

The asset composition has shifted significantly, with goodwill nearly eliminated, suggesting that management has recognized that prior acquisitions were overvalued. PPE has also declined from $790.1M to $608.0M, reflecting either divestitures or reduced capital investment. The remaining asset base is more focused on tangible assets, which may be positive for transparency but also indicates a lack of growth investments. The sharp reduction in assets suggests a company in contraction mode, not expansion.

Retained Earnings Drain Accelerates

Retained earnings fell from $946.3M to $500.0M in Q2 2026, a 47% decline, according to the balance sheet, reflecting cumulative losses that have consumed a significant portion of historical profits.

The decline in retained earnings is a direct result of the net losses incurred over the past two years, including the large impairment charges. This has severely reduced the company's equity cushion and its ability to absorb future shocks. The negative net margin of -14.3% in recent quarters, despite a positive operating margin, indicates that non-operating charges are eroding shareholder value. Investors should monitor whether the company can return to sustained profitability to rebuild its equity base.

Liquidity Improves but Cash Buffer Thin

Current ratio improved to 1.61 in Q2 2026 from 1.27 a year earlier, while cash rose to $97.4M, as per the balance sheet, but the cash position remains modest relative to debt.

The improvement in the current ratio suggests better short-term liquidity management, possibly through inventory reductions or improved receivables collection. However, cash of $97.4M is small compared to total debt of $1.2B, leaving little room for error if operating cash flows remain volatile. The negative operating cash flow in Q2 2026 highlights the fragility of the liquidity position, and the company may need to rely on external financing or asset sales to meet obligations.

Goodwill Impairment Distorts Leverage

The near-total write-off of goodwill, from $525.9M to $4.3M, has artificially inflated the D/E ratio, as reported in the balance sheet, masking the underlying operational leverage.

The dramatic reduction in goodwill has removed a large intangible asset from the balance sheet, which has the effect of increasing the D/E ratio even though the company's actual debt burden has not changed significantly. This distortion makes the headline leverage metrics appear more alarming than they might be on an operational basis. However, the write-downs also signal that past acquisitions have failed to deliver expected synergies, which is a fundamental concern about management's capital allocation. Investors should adjust for these non-cash charges to assess the true leverage and asset quality.

NGVT — Frequently Asked Questions

Quick answers to the most common questions about buying NGVT stock.

What are the total assets of Ingevity Corporation (NGVT)?

As of 2025, Ingevity Corporation (NGVT) had total assets of $1.65B including $391.3M in current assets.

How much debt does Ingevity Corporation (NGVT) have?

Ingevity Corporation (NGVT) carries total debt of $1.24B, offset by $78.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Ingevity Corporation?

Ingevity Corporation (NGVT) has total shareholders' equity (book value) of $29.7M ($0.82 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Ingevity Corporation's current ratio and liquidity?

Ingevity Corporation (NGVT) reported a current ratio of 1.15x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.